Ki Summary BindingDB logo
myBDB logout
Reaction Details
Report a problem with these data
TargetSomatostatin receptor type 5
LigandBDBM84988
Substrate/Competitorn/a
Ki 12.58±n/a nM
CommentsPDSP_1767
Citation Bruns, C; Raulf, F; Hoyer, D; Schloos, J; Lübbert, H; Weckbecker, G Binding properties of somatostatin receptor subtypes. Metab Clin Exp45:17-20 (1996) [PubMed]  Article
More Info.:Get all data from this article
 
Somatostatin receptor type 5
Name:Somatostatin receptor type 5
Synonyms:SOMATOSTATIN SST5 | SS-5-R | SS5-R | SS5R | SSR5_HUMAN | SSTR5 | Somatostatin receptor type 5 (SSTR5)
Type:Enzyme
Mol. Mass.:39218.02
Organism:Homo sapiens (Human)
Description:P35346
Residue:364
Sequence:
MEPLFPASTPSWNASSPGAASGGGDNRTLVGPAPSAGARAVLVPVLYLLVCAAGLGGNTL
VIYVVLRFAKMKTVTNIYILNLAVADVLYMLGLPFLATQNAASFWPFGPVLCRLVMTLDG
VNQFTSVFCLTVMSVDRYLAVVHPLSSARWRRPRVAKLASAAAWVLSLCMSLPLLVFADV
QEGGTCNASWPEPVGLWGAVFIIYTAVLGFFAPLLVICLCYLLIVVKVRAAGVRVGCVRR
RSERKVTRMVLVVVLVFAGCWLPFFTVNIVNLAVALPQEPASAGLYFFVVILSYANSCAN
PVLYGFLSDNFRQSFQKVLCLRKGSGAKDADATEPRPDRIRQQQEATPPAHRAAANGLMQ
TSKL
Blast this sequence in BindingDB or PDB
  Blast E-value cutoff:
BDBM84988
n/a
NameBDBM84988
Synonyms:SS-22
TypeSmall organic molecule
Emp. Form.C111H170N31O34S3
Mol. Mass.2578.919
SMILESCSCCC1NC(=O)C(CSSCC(NC(=O)C(C)NC(=O)C(NC(=O)C(CCC[NH+]=C(N)N)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(CC(N)=O)NC1=O)C(C)O)C(O)=O)NC(=O)C(CC(N)=O)NC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(CC(N)=O)NC(=O)C(N)CC(O)=O)C(C)O)C(C)C)C(C)O |(36.91,8.16,;36.91,6.63,;35.58,6.14,;35.58,4.56,;36.95,3.94,;37.07,2.37,;35.67,1.58,;34.38,2.37,;35.67,.01,;37.07,-.73,;36.95,-2.31,;38.36,-2.89,;38.52,-4.46,;37.16,-5.2,;37.16,-6.78,;38.56,-7.44,;38.56,-8.97,;39.89,-6.65,;39.89,-5.16,;41.21,-7.48,;42.54,-6.57,;42.41,-5.04,;43.94,-7.31,;45.23,-6.57,;45.23,-5.04,;43.86,-4.38,;46.51,-4.17,;47.92,-4.83,;48.69,-6.16,;47.92,-7.5,;48.69,-8.83,;47.92,-10.17,;48.69,-11.5,;46.38,-10.17,;46.34,-2.64,;47.71,-1.89,;47.71,-.36,;49.07,-2.6,;49.28,-4.13,;50.69,-4.75,;50.48,-1.81,;50.36,-.24,;48.99,.42,;51.68,.55,;53.01,-.28,;54.21,.63,;55.49,-.2,;56.69,.71,;56.23,2.16,;51.68,2.12,;50.32,2.78,;49.07,1.96,;50.32,4.36,;51.6,5.22,;52.92,4.4,;53.05,2.95,;54.54,2.58,;55.28,3.9,;56.81,4.15,;57.27,5.68,;56.23,6.84,;54.7,6.51,;54.29,5.02,;48.91,5.14,;47.63,4.27,;47.75,2.78,;46.22,4.94,;46.09,6.51,;47.5,7.29,;47.5,8.78,;48.78,9.61,;50.11,8.87,;50.11,7.34,;48.83,6.55,;44.94,4.03,;43.53,4.85,;42.2,4.11,;43.53,6.43,;44.89,7.13,;44.73,8.74,;46.01,9.53,;46.01,11.1,;44.69,11.85,;44.69,13.39,;43.36,11.02,;43.36,9.45,;42.16,7.25,;40.92,6.38,;40.92,4.85,;39.47,7.13,;39.35,8.66,;40.76,9.32,;40.76,10.81,;41.96,8.45,;38.15,6.34,;38.27,4.77,;39.64,4.15,;43.94,-8.8,;42.58,-9.59,;45.23,-9.55,;35.83,-4.5,;34.55,-5.29,;35.83,-3.01,;34.38,-.86,;33.02,-.11,;33.02,1.42,;31.69,-.9,;31.69,-2.44,;30.6,-3.53,;29.12,-3.13,;30.6,-5.07,;30.45,.05,;29.17,-.82,;29.25,-2.31,;27.76,-.15,;27.6,1.38,;28.69,2.47,;28.69,4.01,;30.17,2.07,;26.48,-1.07,;25.16,-.28,;25.16,1.25,;23.79,-1.02,;23.79,-2.6,;22.84,-2.98,;22.07,-1.64,;22.47,-.15,;21.22,-.98,;21.22,-2.47,;19.82,-.24,;19.69,1.34,;21.02,1.96,;21.02,3.53,;22.34,4.15,;22.34,5.69,;18.53,-1.15,;17.29,-.32,;17.29,1.17,;15.93,-1.02,;15.93,-2.6,;17.34,-3.21,;14.64,-.2,;13.4,-1.07,;13.53,-2.6,;12.08,-.44,;10.8,-1.31,;9.76,-.4,;10.18,1.09,;8.27,-.65,;6.78,-.15,;5.5,-1.02,;5.62,-2.6,;4.09,-.4,;2.81,-1.35,;1.53,-.53,;1.53,.96,;.16,-1.27,;.16,-2.8,;1.57,-3.38,;2.9,-2.61,;1.57,-4.92,;-1.16,-.49,;-2.36,-1.44,;-2.12,-2.97,;-3.73,-.94,;-4.93,-1.85,;-3.94,.59,;-2.85,1.68,;-1.36,1.28,;-3.25,3.17,;3.93,1.13,;2.84,2.22,;5.26,1.9,;8.27,-2.19,;6.94,-2.96,;9.61,-2.96,;11.95,1.13,;13.32,1.79,;10.87,2.22,)|
Structure
Search PDB for entries with ligand similarity:Similarity to this molecule at least: